Abiopharma

🔍 Tan Irving (Director)

Company: WESTERN DIGITAL CORP (WDC)

Report Date: 2026-08-20

Detailed Transactions and Holdings:

• Acquired 13 shares of Common Stock (Direct)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 575,979.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 144 shares of Common Stock at $469.05 per share (Direct)
  Date: 2026-08-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 575,835.00 | transaction_form_type: 4 | Footnotes: F2
• Acquired 25 shares of Common Stock (Direct)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 575,860.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 545 shares of Common Stock at $459.44 per share (Direct)
  Date: 2026-08-21 | Code: F | equity_swap_involved: 0 | shares_owned_after: 575,315.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 13 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-08-20 | Code: M | equity_swap_involved: 0 | shares_owned_after: 873.40 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Sold 25 shares of Dividend Equivalent Rights (Derivative)
  Date: 2026-08-21 | Code: M | equity_swap_involved: 0 | shares_owned_after: 848.39 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: The dividend equivalent rights were converted into, and paid in the form of, shares of the Issuer's common stock on a one-for-one basis in connection with the vesting of restricted stock units to which the dividend equivalent rights relate. A cash amount was also paid to the holder to settle a fractional dividend equivalent right.
• F2: Payment of tax obligation by withholding securities incident to the vesting of securities in accordance with Rule 16b-3(e).